BP |
GO: 0009615 |
Response to virus |
75 |
9.27E-60 |
GO: 0051607 |
Defense response to virus |
67 |
1.20E-59 |
GO: 0034341 |
Response to interferon-gamma |
51 |
5.09E-43 |
GO: 0060337 |
Type I interferon signaling pathway |
38 |
1.25E-40 |
GO: 0071357 |
Cellular response to type i interferon |
38 |
1.25E-40 |
GO: 0034340 |
Response to type i interferon |
38 |
8.46E-40 |
GO: 0071346 |
Cellular response to interferon-gamma |
45 |
1.81E-37 |
GO: 0048525 |
Negative regulation of viral process |
33 |
2.80E-32 |
GO: 0060333 |
Interferon-gamma-mediated signaling pathway |
32 |
3.39E-32 |
GO: 1903901 |
Negative regulation of viral life cycle |
31 |
8.43E-32 |
MF |
GO: 0005125 |
Cytokine activity |
29 |
1.03E-15 |
GO: 0048018 |
Receptor ligand activity |
39 |
1.62E-13 |
GO: 0005126 |
Cytokine receptor binding |
29 |
9.81E-13 |
GO: 0042379 |
Chemokine receptor binding |
13 |
5.95E-10 |
GO: 0008009 |
Chemokine activity |
11 |
2.92E-09 |
GO: 0045236 |
CXCR chemokine receptor binding |
6 |
2.79E-08 |
GO: 0003725 |
Double-stranded RNA binding |
12 |
3.25E-08 |
GO: 0016814 |
Hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines |
7 |
4.39E-06 |
GO: 0042056 |
Chemoattractant activity |
7 |
9.61E-06 |
GO: 0048020 |
CCR chemokine receptor binding |
7 |
2.25E-05 |